Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

OW 2026 15 November 2026

The predicted impact of CagriSema for the primary prevention of cardiovascular disease in the US population with overweight or obesity

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
Cardiovascular Disease
Congress poster
GLP-1 RA
CagriSema
RWE